These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35700756)

  • 1. Madecassic acid alleviates colitis-associated colorectal cancer by blocking the recruitment of myeloid-derived suppressor cells via the inhibition of IL-17 expression in γδT17 cells.
    Yun X; Zhang Q; Fang Y; Lv C; Chen Q; Chu Y; Zhu Y; Wei Z; Xia Y; Dai Y
    Biochem Pharmacol; 2022 Aug; 202():115138. PubMed ID: 35700756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.
    Lu ZH; Ding Y; Wang YJ; Chen C; Yao XR; Yuan XM; Bu F; Bao H; Dong YW; Zhou Q; Li L; Chen T; Li Y; Zhou JY; Wang Q; Shi GP; Jiang F; Chen YG
    J Ethnopharmacol; 2024 Oct; 333():118260. PubMed ID: 38685367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the activation of γδT17 cells through PPARγ-PTEN/Akt/GSK3β/NFAT pathway contributes to the anti-colitis effect of madecassic acid.
    Yun X; Fang Y; Lv C; Qiao S; Tao Y; Dai Y; Xia Y
    Cell Death Dis; 2020 Sep; 11(9):752. PubMed ID: 32929062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
    Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
    Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.
    Cui H; Jin Y; Wang N; Liu H; Shu R; Wang J; Wang X; Jia B; Wang Y; Bian Y; Wen W
    Phytomedicine; 2024 Jun; 128():155509. PubMed ID: 38452403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
    Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
    Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway.
    Xu X; Wang Y; Wei Z; Wei W; Zhao P; Tong B; Xia Y; Dai Y
    Cell Death Dis; 2017 Mar; 8(3):e2723. PubMed ID: 28358365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30L/CD30 signaling regulates the formation of the tumor immune microenvironment and inhibits intestinal tumor development of colitis-associated colon cancer in mice.
    Wang X; Gao Y; Zhang X; Wang X; Wang B; Meng X; Yoshikai Y; Wang Y; Sun X
    Int Immunopharmacol; 2020 Jul; 84():106531. PubMed ID: 32353687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway.
    Pan D; Huang B; Gan Y; Gao C; Liu Y; Tang Z
    Mar Drugs; 2022 Apr; 20(4):. PubMed ID: 35447933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.
    Wang J; Ding K; Wang Y; Yan T; Xu Y; Deng Z; Lin W; Zhang L; Zhu W; Zhao R; Zhou Y; Liu Z
    Oxid Med Cell Longev; 2022; 2022():4061713. PubMed ID: 35927991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer.
    Xun J; Zhou S; Lv Z; Wang B; Luo H; Zhang L; Yang L; Zhang A; Wu X; Wang Z; Wang X; Yu X; Zhang Q
    Int Immunopharmacol; 2023 Apr; 117():109839. PubMed ID: 36809720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
    He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
    Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AOM/DSS Induced Colitis-Associated Colorectal Cancer in 14-Month-Old Female Balb/C and C57/Bl6 Mice-A Pilot Study.
    Schepelmann M; Kupper N; Gushchina V; Mesteri I; Manhardt T; Moritsch S; Müller C; Piatek K; Salzmann M; Vlasaty A; Eferl R; Kallay E
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural shikonin and acetyl-shikonin improve intestinal microbial and protein composition to alleviate colitis-associated colorectal cancer.
    Lin H; Ma X; Yang X; Chen Q; Wen Z; Yang M; Fu J; Yin T; Lu G; Qi J; Han H; Yang Y
    Int Immunopharmacol; 2022 Oct; 111():109097. PubMed ID: 35952517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 4 prevents AOM/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice.
    Lee YP; Huang WC; Lin TJ; Chiu CC; Wang YC; Chen YH; Hung SW; Chuang HL; Chen TH
    Hum Exp Toxicol; 2021 Apr; 40(4):622-633. PubMed ID: 32924602
    [No Abstract]   [Full Text] [Related]  

  • 16. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
    Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated Cancer (CAC).
    Sun A; Ge J; Ding K; Gao Z; Zhang Y
    Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
    Wang L; Hu D; Xie B; Xie L
    Invest New Drugs; 2022 Jun; 40(3):506-518. PubMed ID: 35089465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-597-5p inhibits carcinogenesis and macrophage recruitment in colitis-related colorectal cancer via reducing the expression of CXCL5.
    Li S; Yu M; Wang X; Fei B
    Cancer Biol Ther; 2023 Dec; 24(1):2274122. PubMed ID: 37942533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.